Jury Finds Illumina Infringed LadaTech DNA Patent

Law360, Los Angeles (February 29, 2012, 9:40 PM EST) -- Illumina Inc.’s DNA sequencing products infringe a LadaTech LLC patent related to genome analysis technology, a Delaware federal jury ruled Tuesday, rejecting Illumina’s claims that the patent is invalid due to anticipation or obviousness.

Tuesday’s ruling handed a clear victory to LadaTech in a long-running fight over allegations that San Diego, Calif.-based biotechnology company Illumina infringed LadaTech's patent — and caused customers to do the same — when it sold DNA sample preparation kits and cluster generation products.

LadaTech filed the suit in the District of...
To view the full article, register now.